Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus

Yulia Alejandra Flores-Martínez1, Vu Thuy Khanh Le-Trilling1, Mirko Trilling1

  • 1Institute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.

Viruses
|August 28, 2021
PubMed

Insights

The Nedd8-activating enzyme (NAE) and its neddylation process are crucial for cytomegalovirus replication. Inhibiting NAE with drugs like MLN4924 and TAS4464 shows potent antiviral activity, identifying NAE as a druggable host dependency factor.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Human cytomegalovirus (CMV) infections pose significant risks to immunocompromised individuals.
  • CMV manipulates host cell proteasome pathways, including cullin RING ligases (CRLs), for replication.
  • CRL activity is regulated by Nedd8 modification, a process dependent on the Nedd8-activating enzyme (NAE).

Purpose of the Study:

  • To investigate the Nedd8-activating enzyme (NAE) as a potential druggable host dependency factor (HDF) for cytomegaloviruses.
  • To validate the antiviral efficacy of NAE inhibitors against both human and mouse CMV.
  • To confirm the specificity of NAE inhibition in conferring antiviral activity.

Main Methods:

  • Utilized the NAE inhibitor MLN4924 (pevonedistat) and a novel NAE inhibitor, TAS4464.
  • Assessed antiviral activity against human and mouse cytomegalovirus strains.
  • Generated and utilized a cell clone resistant to MLN4924 to evaluate drug specificity.

Main Results:

  • Both MLN4924 and TAS4464 demonstrated potent antiviral activity against cytomegaloviruses.
  • Antiviral activity of both NAE inhibitors was significantly reduced or abolished in the MLN4924-resistant cells.
  • These findings strongly suggest NAE is essential for CMV replication.

Conclusions:

  • The Nedd8-activating enzyme (NAE), the neddylation process, and CRLs represent viable and druggable host dependency factors for cytomegaloviruses.
  • Targeting NAE offers a promising therapeutic strategy for managing CMV infections, particularly in vulnerable populations.

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...